360 ONE Wam
360 ONE is set to back Asian Institute of Medical Sciences (AIMS) founder Narendra Pandey to buy back a 49% stake that private equity investors hold in the Faridabad hospital, people familiar with the matter said.Vedanta
Business conglomerate Vedanta Group has approached the National Company Law Appellate Tribunal (NCLAT), challenging the NCLT’s approval to Adani Group‘s bid for acquiring Jaiprakash Associates Ltd for Rs 14,535 crore. Anil Agarwal-led Vedanta Group was in the race to acquire Jaiprakash Associates Ltd (JAL) through an insolvency process, but the lenders in November last year approved the resolution plan or bid of Adani Enterprises.
Tata Motors PV
Tata Motors Passenger Vehicles Ltd. (TMPV), one of India’s leading car and SUV manufacturers, said on Friday that it will increase prices of its passenger vehicles, effective April 1, 2026.
Tata Capital
Non-banking finance company Tata Capital has received a reassessment order from tax authorities, raising a demand of Rs 413.18 crore for the financial year 2017-18, the firm said.Godrej Properties
Godrej Properties and Lodha Developers are bullish on India’s housing demand, as both realty firms have acquired more than 25 land parcels so far this fiscal year to develop residential projects with a combined revenue potential of more than Rs 1 lakh crore.Torrent Pharma
Torrent Pharma launched oral and injectable formulations of semaglutide at a price of Rs 3,999 per month. Semaglutide launched under brand names ‘Sembolic’ and ‘Semalix’
Dr Reddy’s
Dr Reddy’s announced the launch of India’s first DCGI-approved semaglutide injection Obeda for Type 2 diabetes The injection is available in 2 mg and 4 mg strengths and will cost Rs 4,200 a month for both strengths. The company said it aims to introduce generic semaglutide in several countries, subject to regulatory approval, as part of Phase-1 launch.